a month ago
LGND
AnalystsAnnabel SamimyAnnabel Samimy's Stock Forecasts
AnalystsAnnabel Samimy
Analyst Ranking
Top 8%
#382 out of 5342 analysts
Average Return
+35.73%
Win Rate
47%35 out of 74
Risk vs Reward
Poor
Good
Annabel Samimy's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Viking Therapeutics IncVKTX | +439.77% | $15.44 | $83.34 | 2023-03-28 - 2024-03-27 | Strong Buy |
Viking Therapeutics IncVKTX | +428.83% | $11.83 | $62.56 | 2023-03-17 - 2024-03-15 | Strong Buy |
Palvella Therapeutics IncPVLA | +331.04% | $27.93 | $120.39 | 2025-03-26 - 2026-03-25 | Strong Buy |
Prometheus Biosciences IncRXDX | +276.85% | $51.35 | $193.51 | 2022-11-01 - 2023-04-17 | Strong Buy |
Viking Therapeutics IncVKTX | +257.67% | $14.22 | $50.86 | 2023-08-08 - 2024-08-07 | Strong Buy |
Annabel Samimy Analyst Color
Get additional color on Annabel Samimy's coverage of popular stocks
5 months ago
OCS
8 months ago
TRVI
8 months ago
RGNX
8 months ago
OCS
8 months ago
MLYS
8 months ago
MBX
8 months ago
LGND
8 months ago
GPCR
8 months ago
PVLA
10 months ago
PVLA
2 years ago
VKTX
2 years ago
JAZZ
2 years ago
EOLS
2 years ago
VKTX
3 years ago
APLS
3 years ago
VKTX
3 years ago
RXDX
3 years ago
RETA
3 years ago
VKTX
Annabel Samimy's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Eyepoint IncEYPT | 1 | Strong Buy | $40.00 | +226.53% | Initiates Coverage On | 19 days ago |
Ligand Pharmaceuticals IncLGND | 3 | Strong Buy | $332.00 | +15.46% | Maintains | a month ago |
Oculis Holding AgOCS | 4 | Strong Buy | $40.00 | +253.67% | Maintains | 2 months ago |
Eupraxia Pharmaceuticals IncEPRX | 1 | Strong Buy | $25.00 | +290.63% | Initiates Coverage On | 2 months ago |
Evolus IncEOLS | 2 | Strong Buy | $17.00 | +191.10% | Maintains | 7 months ago |
Trevi Therapeutics IncTRVI | 1 | Strong Buy | $18.00 | -1.37% | Maintains | 8 months ago |
Supernus Pharmaceuticals IncSUPN | 5 | Hold | $55.00 | +23.24% | Maintains | 8 months ago |
Regenxbio IncRGNX | 3 | Strong Buy | $45.00 | +364.40% | Maintains | 8 months ago |
Mineralys Therapeutics IncMLYS | 2 | Strong Buy | $52.00 | +103.76% | Maintains | 8 months ago |
Mbx Biosciences IncMBX | 2 | Strong Buy | $50.00 | -24.16% | Maintains | 8 months ago |
Apellis Pharmaceuticals IncAPLS | 4 | Strong Buy | $48.00 | +16.99% | Maintains | 8 months ago |
Structure Therapeutics IncGPCR | 2 | Strong Buy | $90.00 | +87.34% | Maintains | 8 months ago |
Palvella Therapeutics IncPVLA | 3 | Strong Buy | $145.00 | +4.29% | Maintains | 8 months ago |
Altimmune IncALT | 1 | Strong Buy | $18.00 | N/A | Initiates Coverage On | 2 years ago |
Inventiva SaIVA | 4 | Strong Buy | $17.00 | N/A | Maintains | 2 years ago |
Revance Therapeutics IncRVNC | 2 | Strong Buy | $20.00 | N/A | Maintains | 2 years ago |
Kamada LtdKMDA | 1 | Strong Buy | $18.00 | N/A | Initiates Coverage On | 2 years ago |
Calliditas Therapeutics AbCALT | 2 | Hold | $40.00 | N/A | Downgrades | 2 years ago |
Phathom Pharmaceuticals IncPHAT | 1 | Strong Buy | $24.00 | N/A | Initiates Coverage On | 2 years ago |
Viking Therapeutics IncVKTX | 6 | Strong Buy | $80.00 | N/A | Reiterates | 2 years ago |
Jazz Pharmaceuticals PLCJAZZ | 3 | Strong Buy | $230.00 | N/A | Maintains | 2 years ago |
Reata Pharmaceuticals IncRETA | 2 | Hold | $172.50 | N/A | Downgrades | 3 years ago |
Tvardi Therapeutics IncTVRD | 4 | Strong Buy | $336.00 | N/A | Reiterates | 3 years ago |
Kyntra Bio IncKYNB | 3 | Hold | $275.00 | N/A | Downgrades | 3 years ago |
Prometheus Biosciences IncRXDX | 2 | Hold | $200.00 | N/A | Downgrades | 3 years ago |
Horizon Therapeutics Public Ltd CoHZNP | 4 | Hold | $116.50 | N/A | Downgrades | 4 years ago |
Clearside Biomedical IncCLSDQ | 1 | Strong Buy | $120.00 | N/A | Upgrades | 4 years ago |
Evofem Biosciences IncEVFM | 2 | Hold | $0.50 | N/A | Downgrades | 4 years ago |
Iveric Bio IncISEE | 2 | Strong Buy | $35.00 | N/A | Maintains | 4 years ago |
Aerie Pharmaceuticals IncAERI | 2 | Hold | $15.25 | N/A | Downgrades | 4 years ago |
Elicio Therapeutics IncELTX | 3 | Hold | $15.00 | N/A | Downgrades | 4 years ago |
Rani Therapeutics Holdings IncRANI | 1 | Strong Buy | $24.00 | N/A | Initiates Coverage On | 5 years ago |
Radius Health IncRDUS1 | 1 | Hold | $20.00 | N/A | Initiates Coverage On | 6 years ago |
Therapeuticsmd IncTXMD | 3 | Strong Buy | $750.00 | N/A | Maintains | 6 years ago |
Durect CorpDRRX | 4 | Hold | $21.00 | N/A | Maintains | 7 years ago |
Zogenix IncZGNX | 2 | Strong Buy | $61.00 | N/A | Maintains | 7 years ago |
Endo International PLCENDPQ | 2 | Hold | $17.00 | N/A | Maintains | 8 years ago |
Innocoll Holdings PLCINNL | 1 | Hold | N/A | N/A | Downgrades | 9 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.